[1]
2024. RP-HPLC Method Development and Validation for Simultaneous Estimation of Erlotinib and Ramucirumab in bulk and Pharmaceutical Dosage form  and its stability studies. International Journal of Pharmaceutical Sciences and Drug Research. 16, 3 (May 2024), 452–457. DOI:https://doi.org/10.25004/IJPSDR.2024.160318.